
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
Publication
, Journal Article
Orange, JS; Hossny, EM; Weiler, CR; Ballow, M; Berger, M; Bonilla, FA; Buckley, R; Chinen, J; El-Gamal, Y; Mazer, BD; Nelson, RP; Patel, DD ...
Published in: J Allergy Clin Immunol
April 2006
Human immunoglobulin prepared for intravenous administration (IGIV) has a number of important uses in the treatment of disease. Some of these are in diseases for which acceptable treatment alternatives do not exist. In this review we have evaluated the evidence underlying a wide variety of IGIV uses and make specific recommendations on the basis of these data. Given the potential risks and inherent scarcity of IGIV, careful consideration of the indications for and administration of IGIV is warranted.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Allergy Clin Immunol
DOI
ISSN
0091-6749
Publication Date
April 2006
Volume
117
Issue
4 Suppl
Start / End Page
S525 / S553
Location
United States
Related Subject Headings
- Skin Diseases
- Risk
- Respiratory Syncytial Virus Infections
- Nervous System Diseases
- Mental Disorders
- Kidney Transplantation
- Immunologic Deficiency Syndromes
- Immunoglobulins, Intravenous
- Immunization, Passive
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Orange, J. S., Hossny, E. M., Weiler, C. R., Ballow, M., Berger, M., Bonilla, F. A., … Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. (2006). Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol, 117(4 Suppl), S525–S553. https://doi.org/10.1016/j.jaci.2006.01.015
Orange, Jordan S., Elham M. Hossny, Catherine R. Weiler, Mark Ballow, Melvin Berger, Francisco A. Bonilla, Rebecca Buckley, et al. “Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.” J Allergy Clin Immunol 117, no. 4 Suppl (April 2006): S525–53. https://doi.org/10.1016/j.jaci.2006.01.015.
Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006 Apr;117(4 Suppl):S525–53.
Orange, Jordan S., et al. “Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.” J Allergy Clin Immunol, vol. 117, no. 4 Suppl, Apr. 2006, pp. S525–53. Pubmed, doi:10.1016/j.jaci.2006.01.015.
Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C, Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006 Apr;117(4 Suppl):S525–S553.

Published In
J Allergy Clin Immunol
DOI
ISSN
0091-6749
Publication Date
April 2006
Volume
117
Issue
4 Suppl
Start / End Page
S525 / S553
Location
United States
Related Subject Headings
- Skin Diseases
- Risk
- Respiratory Syncytial Virus Infections
- Nervous System Diseases
- Mental Disorders
- Kidney Transplantation
- Immunologic Deficiency Syndromes
- Immunoglobulins, Intravenous
- Immunization, Passive
- Humans